Neurogene Competitors and Similar CompaniesClear all

Neurogene's competitors and similar companies include ZZ Biotech, Dyne Therapeutics, Graphite Bio and Ambrx.

	Neurogene Neurogene is a biotechnology company which accelerates the development of genetic medicines to people with devastating neurological diseases.	ZZ Biotech ZZ Biotech is a company developing biological treatments for ischemic stroke and other neurological diseases.	Dyne Therapeutics Dyne Therapeutics is a biotechnology company which is engaged in the development of targeted therapies for patients with serious muscle diseases.	Graphite Bio Graphite Bio is a gene-editing company focused on the development of therapies for patients suffering from life-threatening genetic diseases.	Ambrx Ambrx is a biopharmaceutical company that discovers and develops engineered precision biologics therapeutics using an expanded genetic code.
Founding Date	Founding Date 2018	Founding Date 2006	Founding Date 2018	Founding Date 2017	Founding Date 2003
Type	Type Private	Type Private	Type Public	Type Public	Type Public
Tags	Tags Healthcare Technology biotech genetics medtech pharma therapy	Tags Healthcare biotech drug development pharma	Tags Healthcare Technology biotech genetics pharma therapy	Tags Healthcare biotech genetics pharma therapy	Tags Healthcare biotech genetics pharma therapy
Locations	Locations New York, US HQ Houston, US	Locations Houston, US HQ Sydney, AU	Locations Waltham, US HQ	Locations South San Francisco, US HQ	Locations San Diego, US HQ
Employees	Employees 1091% decrease	Employees 6810% increase	Employees 1451% decrease	Employees 27	Employees 70
Valuation ($)	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 3.1 b	Valuation ($) 185.2 m	Valuation ($) 1.8 b
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) $19.1m (FY, 2025)	Revenue (est.) $7.4m (FY, 2022)
Net income	Net income N/A	Net income N/A	Net income ($446.2m) (FY, 2025)	Net income ($82.1m) (FY, 2025)	Net income ($78m) (FY, 2022)
Funding
Latest funding round	Latest funding round $ 68.5m (about 7 years ago)	Latest funding round $ 6.9m (over 11 years ago)	Latest funding round N/A	Latest funding round N/A	Latest funding round N/A
Total funding raised	Total funding raised $ 68.5m	Total funding raised $ 7.9m	Total funding raised $ 165m	Total funding raised N/A	Total funding raised $ 347.9m